All companies › ATRC

ATRC · AtriCure, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells5
Research cases0
Last filing2026-09-23

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-24 — Dahlquist Karl S. · sold 9,370 @ $48.89 2026-09-02 — Privitera Salvatore · sold 7,763 @ $52.50 2026-09-08 — Privitera Salvatore · sold 3,657 @ $55.00 2026-09-11 — GROVES REGINA E · sold 5,313 @ $54.22 2026-09-23 — Privitera Salvatore · sold 4,519 @ $60.00
2026-08-242026-09-23

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Privitera Salvatore Chief Technical Officer
Dahlquist Karl S. Chief Legal Officer
GROVES REGINA E Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ATRC is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-23', 'insider_name': 'Privitera Salvatore', 'insider_title': 'Chief Technical Officer', 'transaction_type': 'Open-market sell', 'shares': 4519.0, 'price': 60.0, 'value': 271140.0, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'GROVES REGINA E', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 5313.0, 'price': 54.22, 'value': 288070.86, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Privitera Salvatore', 'insider_title': 'Chief Technical Officer', 'transaction_type': 'Open-market sell', 'shares': 3657.0, 'price': 55.0, 'value': 201135.0, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Privitera Salvatore', 'insider_title': 'Chief Technical Officer', 'transaction_type': 'Open-market sell', 'shares': 7763.0, 'price': 52.5, 'value': 407557.5, 'is_buy': False}, {'transaction_date': '2026-08-24', 'insider_name': 'Dahlquist Karl S.', 'insider_title': 'Chief Legal Officer', 'transaction_type': 'Open-market sell', 'shares': 9370.0, 'price': 48.89, 'value': 458099.3, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ATRC today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.